Literature DB >> 11972327

Design of antisense oligonucleotides stabilized by locked nucleic acids.

Jens Kurreck1, Eliza Wyszko, Clemens Gillen, Volker A Erdmann.   

Abstract

The design of antisense oligonucleotides containing locked nucleic acids (LNA) was optimized and compared to intensively studied DNA oligonucleotides, phosphorothioates and 2'-O-methyl gapmers. In contradiction to the literature, a stretch of seven or eight DNA monomers in the center of a chimeric DNA/LNA oligonucleotide is necessary for full activation of RNase H to cleave the target RNA. For 2'-O-methyl gapmers a stretch of six DNA monomers is sufficient to recruit RNase H. Compared to the 18mer DNA the oligonucleotides containing LNA have an increased melting temperature of 1.5-4 degrees C per LNA depending on the positions of the modified residues. 2'-O-methyl nucleotides increase the T(m) by only <1 degree C per modification and the T(m) of the phosphorothioate is reduced. The efficiency of an oligonucleotide in supporting RNase H cleavage correlates with its affinity for the target RNA, i.e. LNA > 2'-O-methyl > DNA > phosphorothioate. Three LNAs at each end of the oligonucleotide are sufficient to stabilize the oligonucleotide in human serum 10-fold compared to an unmodified oligodeoxynucleotide (from t(1/2) = approximately 1.5 h to t(1/2) = approximately 15 h). These chimeric LNA/DNA oligonucleotides are more stable than isosequential phosphorothioates and 2'-O-methyl gapmers, which have half-lives of 10 and 12 h, respectively.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11972327      PMCID: PMC113840          DOI: 10.1093/nar/30.9.1911

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  28 in total

1.  Properties of cloned and expressed human RNase H1.

Authors:  H Wu; W F Lima; S T Crooke
Journal:  J Biol Chem       Date:  1999-10-01       Impact factor: 5.157

Review 2.  Progress in antisense technology: the end of the beginning.

Authors:  S T Crooke
Journal:  Methods Enzymol       Date:  2000       Impact factor: 1.600

3.  New candidates for true antisense.

Authors:  J J Toulmé
Journal:  Nat Biotechnol       Date:  2001-01       Impact factor: 54.908

Review 4.  A review of the issues in the pharmacokinetics and toxicology of phosphorothioate antisense oligonucleotides.

Authors:  A A Levin
Journal:  Biochim Biophys Acta       Date:  1999-12-10

5.  Potent and nontoxic antisense oligonucleotides containing locked nucleic acids.

Authors:  C Wahlestedt; P Salmi; L Good; J Kela; T Johnsson; T Hökfelt; C Broberger; F Porreca; J Lai; K Ren; M Ossipov; A Koshkin; N Jakobsen; J Skouv; H Oerum; M H Jacobsen; J Wengel
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

Review 6.  Locked nucleic acid (LNA): fine-tuning the recognition of DNA and RNA.

Authors:  D A Braasch; D R Corey
Journal:  Chem Biol       Date:  2001-01

Review 7.  A critical survey of the structure-function of the antisense oligo/RNA heteroduplex as substrate for RNase H.

Authors:  E Zamaratski; P I Pradeepkumar; J Chattopadhyaya
Journal:  J Biochem Biophys Methods       Date:  2001-05-28

8.  Nucleotides LXIV[1]: synthesis hydridization and enzymatic degradation studies of 2'-O-methyloligoribonucleotides and 2'-O-methyl/deoxy gapmers.

Authors:  H Cramer; W Pfleiderer
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2000 Oct-Dec       Impact factor: 1.381

Review 9.  Antisense oligonucleotides: promise and reality.

Authors:  I Lebedeva; C A Stein
Journal:  Annu Rev Pharmacol Toxicol       Date:  2001       Impact factor: 13.820

10.  Structural studies of LNA:RNA duplexes by NMR: conformations and implications for RNase H activity.

Authors:  K Bondensgaard; M Petersen; S K Singh; V K Rajwanshi; R Kumar; J Wengel; J P Jacobsen
Journal:  Chemistry       Date:  2000-08-04       Impact factor: 5.236

View more
  153 in total

1.  Antisense inhibition of gene expression in cells by oligonucleotides incorporating locked nucleic acids: effect of mRNA target sequence and chimera design.

Authors:  Dwaine A Braasch; Yinghui Liu; David R Corey
Journal:  Nucleic Acids Res       Date:  2002-12-01       Impact factor: 16.971

2.  RNA cleaving '10-23' DNAzymes with enhanced stability and activity.

Authors:  Steffen Schubert; Deniz C Gül; Hans-Peter Grunert; Heinz Zeichhardt; Volker A Erdmann; Jens Kurreck
Journal:  Nucleic Acids Res       Date:  2003-10-15       Impact factor: 16.971

3.  Use of locked nucleic acid oligonucleotides to add functionality to plasmid DNA.

Authors:  Kirsten M L Hertoghs; Jonathan H Ellis; Ian R Catchpole
Journal:  Nucleic Acids Res       Date:  2003-10-15       Impact factor: 16.971

4.  LNA/DNA chimeric oligomers mimic RNA aptamers targeted to the TAR RNA element of HIV-1.

Authors:  Fabien Darfeuille; Jens Bo Hansen; Henrik Orum; Carmelo Di Primo; Jean-Jacques Toulmé
Journal:  Nucleic Acids Res       Date:  2004-06-04       Impact factor: 16.971

5.  Strong positional preference in the interaction of LNA oligonucleotides with DNA polymerase and proofreading exonuclease activities: implications for genotyping assays.

Authors:  Daniel A Di Giusto; Garry C King
Journal:  Nucleic Acids Res       Date:  2004-02-18       Impact factor: 16.971

Review 6.  Strategies to Modulate MicroRNA Functions for the Treatment of Cancer or Organ Injury.

Authors:  Tae Jin Lee; Xiaoyi Yuan; Keith Kerr; Ji Young Yoo; Dong H Kim; Balveen Kaur; Holger K Eltzschig
Journal:  Pharmacol Rev       Date:  2020-07       Impact factor: 25.468

7.  Comparative crystallization and preliminary X-ray diffraction studies of locked nucleic acid and RNA stems of a tenascin C-binding aptamer.

Authors:  Charlotte Förster; Arnd B E Brauer; Svenja Brode; Kathrin S Schmidt; Markus Perbandt; Arne Meyer; Wojciech Rypniewski; Christian Betzel; Jens Kurreck; Jens P Fürste; Volker A Erdmann
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-06-10

8.  Improved in situ hybridization efficiency with locked-nucleic-acid-incorporated DNA probes.

Authors:  Kengo Kubota; Akiyoshi Ohashi; Hiroyuki Imachi; Hideki Harada
Journal:  Appl Environ Microbiol       Date:  2006-08       Impact factor: 4.792

Review 9.  MicroRNAs: key modulators of posttranscriptional gene expression.

Authors:  Steven P O'Hara; Justin L Mott; Patrick L Splinter; Gregory J Gores; Nicholas F LaRusso
Journal:  Gastroenterology       Date:  2008-12-03       Impact factor: 22.682

Review 10.  DNA and RNA derivatives to optimize distribution and delivery.

Authors:  Eric Wickstrom
Journal:  Adv Drug Deliv Rev       Date:  2015-04-22       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.